Models of human lung airways and their application to inhaled particle deposition.
about
Lung dosimetry and risk assessment of nanoparticles: evaluating and extending current models in rats and humansInhalation exposure to carbon nanotubes (CNT) and carbon nanofibers (CNF): methodology and dosimetryMeasurements of Deposition, Lung Surface Area and Lung Fluid for Simulation of Inhaled CompoundsLung Structure and the Intrinsic Challenges of Gas ExchangeToxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studiesCharacterization of respiratory drug delivery with enhanced condensational growth using an individual path model of the entire tracheobronchial airwaysTargeted Lung Delivery of Nasally Administered AerosolsTargeting aerosol deposition to and within the lung airways using excipient enhanced growthComparative computational modeling of airflows and vapor dosimetry in the respiratory tracts of rat, monkey, and humanPotential health impact of ultrafine particles under clean and polluted urban atmospheric conditions: a model-based studyTranslational toxicology in setting occupational exposure limits for dusts and hazard classification - a critical evaluation of a recent approach to translate dust overload findings from rats to humansEffect of intersubject variability of extrathoracic morphometry, lung airways dimensions and respiratory parameters on particle depositionKinetics of satratoxin g tissue distribution and excretion following intranasal exposure in the mouseEvaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial modelSystems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of TuberculosisDeposition and clearance of inhaled particlesDevelopment of a rhesus monkey lung geometry model and application to particle deposition in comparison to humansLong-term clearance from small airways in patients with chronic bronchitis: experimental and theoretical data.Validating CFD Predictions of Pharmaceutical Aerosol Deposition with In Vivo DataMutual enhancements of CFD modeling and experimental data: a case study of 1-mum particle deposition in a branching airway model.Quantitative risk analysis of particulate matter in the air: interspecies extrapolation with bioassay and mathematical models.Modelling particle deposition in human lungs: modelling concepts and comparison with experimental data.Deposition of combustion aerosols in the human respiratory tract: comparison of theoretical predictions with experimental data considering nonspherical shape.Development of characteristic upper tracheobronchial airway models for testing pharmaceutical aerosol deliveryStachybotrys chartarum, trichothecene mycotoxins, and damp building-related illness: new insights into a public health enigma.Dosimetry modeling of highly soluble reactive gases in the respiratory tract.Thoracic and respirable particle definitions for human health risk assessmentDeposition of Particles in the Alveolar Airways: Inhalation and Breath-Hold with Pharmaceutical Aerosols.A methodological framework for drug development in rare diseases.Long-term carcinogenicity study in Syrian golden hamster of particulate emissions from coal- and oil-fired power plantsIn vitro surfactant and perfluorocarbon aerosol deposition in a neonatal physical model of the upper conducting airways.Informing selection of nanomaterial concentrations for ToxCast in vitro testing based on occupational exposure potentialIn silico models of aerosol delivery to the respiratory tract - development and applications.Targeted delivery of liquid microvolumes into the lung.Review and analysis of inhalation dosimetry methods for application to children's risk assessment.The Creation and Statistical Evaluation of a Deterministic Model of the Human Bronchial Tree from HRCT Images.A computer model for the simulation of nanoparticle deposition in the alveolar structures of the human lungs.Spatial visualization of theoretical nanoparticle deposition in the human respiratory tract.Performance of combination drug and hygroscopic excipient submicrometer particles from a softmist inhaler in a characteristic model of the airways.Current Inhalers Deliver Very Small Doses to the Lower Tracheobronchial Airways: Assessment of Healthy and Constricted Lungs.
P2860
Q23912282-3421CC3B-732E-411C-AB32-DB9384F90451Q23913295-FD8C3824-5FBE-48F8-8506-9CE560AB2647Q26738341-8F351FC5-A6E9-448E-A02B-14C5730405A1Q28075747-59F86DA8-C78F-46CF-AC6D-352CA030DB84Q28383383-787F85D7-C650-4D39-A736-EF9470706508Q28386376-EAEE3BB9-AEE9-4F7F-81D4-665AD6A35B4FQ28387568-5A41B407-A54E-4A6E-A103-CBDDA3CAA690Q28390979-8830355C-58D5-475D-B707-216B7998B4EBQ28392115-20DE1E6E-DA04-42CD-8C0D-636947711800Q28394451-A97CF5B6-89BB-47B6-981C-E415C51F2142Q28394812-567A121D-C961-434A-BC42-27FF000C9FE4Q28395492-13AD3127-7002-42CB-B846-F503B3DCBE2EQ28397327-1C377AF5-AAC1-47A2-B57C-A78FA1C5A799Q28397573-EFB3A2BC-8257-4060-B2E9-219040FD9D4EQ28649769-41F9DAE2-A706-433C-A309-4021FA784303Q28767735-1ADF100C-BB61-4C9E-94EC-EA732ED2C9D4Q28820797-048944CD-D4FB-4828-9CAE-32E828D90BFDQ30938989-F4001B53-9D83-49BF-889B-FDCF44FE0D5DQ30945192-B16C45A4-AB47-4E6F-96B1-C219A2C0178FQ31044257-6C67EEB9-15DD-484F-97F5-7343DEDC1D8EQ33257175-3103479F-E420-480B-81D9-B777189F9A59Q33482404-8C550AA0-03D8-4319-91FA-DE311D626264Q33510424-69506460-B6D4-4E0C-8F72-B6C03128277AQ33626905-1E57F4A9-0401-439E-81DA-F3695990DDEFQ34008209-F2D3B14A-CE9F-483A-90CC-B0F83846FA6FQ34214581-A33D6BD9-05A5-4734-96F3-2499B0B76E4AQ34338432-86F6D65A-8D4D-457E-A9A6-FFD51F3F62BDQ34453318-E27A067C-3722-42D2-A5CE-4BAFFD49FD3BQ34632424-68A45688-2F0A-4557-80B5-594A3DF1BC26Q34660469-4F9F1000-A984-48B7-A896-80BE71BC2764Q35248188-62939B55-AF2C-4729-8EC2-99437903C224Q35579934-15F543A9-D0EB-44D4-9BBC-9E2A79E6C385Q35673202-DC52CDE0-5002-4638-9464-5DA3641EEB3CQ36078988-5407DDE0-7002-4FE1-B62C-407FCB390267Q36131290-B16DFBB2-3FE6-489B-B2DE-D1D3E4EF41C2Q36224916-1F704EBE-D730-48A1-AAF8-CC935465B40CQ36352513-79F8F3D3-3E23-4702-B5F3-20C465CB3CA2Q36403872-1D6D29C1-8AF3-40D8-AFDD-6D9954DEF69BQ36417205-411D88CA-3E98-4A31-B72B-F47019E7CC55Q36559720-7AB794F7-4858-4B74-BBCD-F989BEDDF9C8
P2860
Models of human lung airways and their application to inhaled particle deposition.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh-hant
name
Models of human lung airways and their application to inhaled particle deposition.
@en
Models of human lung airways and their application to inhaled particle deposition.
@nl
type
label
Models of human lung airways and their application to inhaled particle deposition.
@en
Models of human lung airways and their application to inhaled particle deposition.
@nl
prefLabel
Models of human lung airways and their application to inhaled particle deposition.
@en
Models of human lung airways and their application to inhaled particle deposition.
@nl
P2860
P356
P1476
Models of human lung airways and their application to inhaled particle deposition.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF02460796
P577
1980-01-01T00:00:00Z